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Abstract
The central aim in this paper is to address variable selection questions in nonlinear and nonparametric
regression. Motivated by statistical genetics, where nonlinear interactions are of particular interest, we
introduce a novel and interpretable way to summarize the relative importance of predictor variables.
Methodologically, we develop the “RelATive cEntrality” (RATE) measure to prioritize candidate genetic
variants that are not just marginally important, but whose associations also stem from significant covary-
ing relationships with other variants in the data. We illustrate RATE through Bayesian Gaussian process
regression, but the methodological innovations apply to other “black box” methods. It is known that non-
linear models often exhibit greater predictive accuracy than linear models, particularly for phenotypes
generated by complex genetic architectures. With detailed simulations and two real data association
mapping studies, we show that applying RATE enables an explanation for this improved performance.
1 Introduction
Classical statistical models and modern machine learning methodology have recently been dichotomized
into two separate groups. The former are often characterized as interpretable modeling approaches and
include conventional methods such as linear and logistic regressions. The latter, however, have sparked
a greater debate as they have been frequently criticized as “black box” techniques with opaque imple-
mentations and uncertain internal workings. Whenever support vector machines or neural networks give
meaningful performance gains over more conventional regression models, a challenge of interpretability
arises. In these situations, it is often questioned what characteristics of the input data are being most
used by the black box. One of the key features leading to these performance gains is the automatic
inclusion of higher order interactions between variables [1]. Popular machine learning kernel functions
and fully connected neural network layers implicitly enumerate all possible nonlinear effects [2]. While
this fact is in itself a partial explanation for improvement gains, we often wish to know precisely which
variables are the most important — with the ultimate goals of furthering scientific understanding and
performing model/feature selection [3].
As our main contribution, we propose a “RelATive cEntrality” measure (RATE) for investigating
variable importance in Bayesian nonlinear models, particularly those considered to be black box. Here,
RATE identifies variables which are not just marginally important, but also those whose data associations
stem from a significant covarying relationship with other variables. Our method is entirely general with
respect to the modeling approach taken — the only requirement being that a method can produce
uncertainty intervals for predictions. As an illustration, we focus on Gaussian process modeling with
Markov chain Monte Carlo (MCMC) inference. In addition, we note that this variable selection approach
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2immediately applies to other methodologies such as Bayesian neural networks [4], Bayesian additive
regression trees [5], and approximate inference methods like variational Bayes [6].
While variable selection is the main utility for our method, we are motivated by the approach of
continuous model expansion [7]: the goal is to build the best fitting or optimally predictive model while
searching over many variables and the interactions between them, but without explicitly worrying about
sparsity. Indeed, this has become a recent focus of statistical methods research, especially in terms of
understanding the relative importance of subsets of candidate predictors with respect to specific predictive
goals [8]. While we believe strongly in regularization as a key ingredient in developing good statistical
models, our choice of Gaussian process priors achieves robust inference without explicitly imposing a
sparsity penalty. The reason to avoid sparsity constraints like the lasso is not just philosophical — as
typically applied L1-regularization suffers from a lack of stability [9, 10], and the use of Laplacian priors
has too been criticized [11]. Simultaneously, we are also motivated by the rise of deep neural networks,
which are typically wildly over-parameterized and yet, when combined with large datasets, can give quite
impressive improvements to model performance.
We assess our proposed approach in the context of association mapping (i.e. inference of significant
variants or loci) in statistical genetics, as a way to highlight data science applications that are driven by
many covarying and interacting predictors. For example, understanding how statistical epistasis between
genes (i.e. the polynomial terms of the variables in the genotype matrix) influence the architecture of traits
and variation in phenotypes is of great interest in genetics applications [12–19]. However, despite studies
that have detected “pervasive epistasis” in many model organisms [20] and improved genomic selection
(i.e. phenotypic prediction) using nonlinear regression models [21], substantial controversies remain [22].
For example, in some settings, association mapping studies have identified many candidates of statistical
epistasis or interactions that contribute to quantitative traits [23], but some of these results can be
explained by additive effects of other unsequenced variants [24]. To date, we have a limited understanding
of this important biological question because it is often difficult to pinpoint how nonlinearities influence
complex prioritization of associated genetic markers. Indeed, it has been suggested that if one aims
to infer biological interactions, statistically modeled interactions and main effect terms should not be
interpreted separately [25, 26]. Our contribution in this paper is therefore of direct scientific relevance
in that RATE will enable scientists to consider embracing machine learning-type approaches by allowing
them to open up the black box.
The remainder of this paper is organized as follows. In Section 2, we briefly detail the Gaussian process
regression model and motivate the need for an effect size (regression coefficient) analog that serves to
characterize the importance of the original input variables in nonparametric methods. In Section 3, we
specify how to conduct association mapping using distributional centrality measures. Here, we also define
the concept of relative centrality (RATE) which provides evidence for the relative importance of each
variable. In Section 4, we show the utility of our methodology on real and simulated data. Finally, we
close with a discussion in Section 5.
2 Motivating Bayesian Nonparametric Framework
In this paper, we propose a relative centrality measure as an interpretable way to summarize the im-
portance of input variables for nonparametric methodologies. We will do this within the context of
association mapping in statistical genetics. This effort will require the utilization of three components:
(i) a motivating probabilistic model, (ii) a notion of an effect size (or regression coefficient) for each ge-
netic variant, and (iii) a statistical metric that determines marker significance. Each of these components
are naturally given in linear regression. Our goal is to provide a computationally tractable way to derive
the same necessary components for nonlinear methods.
In this section, we focus on formulating components (i) and (ii), while component (iii) is developed
later in Section 3. First, we begin by detailing Bayesian Gaussian process regression as our motivating
3probabilistic model. Next, we generalize a previous result which defines an effect size (regression co-
efficient) analog for the input data in nonparametric methods [27]. Extensions to other methodologies
(e.g. Bayesian kernel ridge regression, neural networks) can be found in Supplementary Material. For
simplicity, we make the assumption that the phenotypic response is continuous; although, the frameworks
discussed can be altered for dichotomous traits (e.g. case-control studies). This expansion would include
steps similar to those outlined in previous works [28]. We leave these specific details to the reader.
2.1 Gaussian Process Regression
We now state a Bayesian modeling framework which we use to construct a generalized projection operator
between an infinite dimensional function space, called a reproducing kernel Hilbert space (RKHS), and
the original genotype space. This projection will allow us to define an effect size analog for Bayesian
nonparametric analyses. We begin by considering standard linear regression
y = Xβ + ε, ε ∼ N (0, τ2I), (1)
where y is an n-dimensional vector of phenotypes from n individuals, X is an n×p matrix of genotypes for
p genetic variants encoded as {0, 1, 2} copies of a reference allele at each marker, β is the corresponding
additive effect size, ε is assumed to follow a multivariate normal distribution with mean zero and variance
τ2, and I is an identity matrix. For convenience, we will also assume that the genotype vector has been
centered and standardized to have mean 0 and standard deviation 1.
In genetic applications, the assumption that phenotypic variation can be fully explained by additive
effects is often too restrictive [13, 17]. One natural way to overcome this problem is to conduct model
inference within a high dimensional function space. Indeed, an RKHS may be defined based on a nonlinear
transformation of the data using a positive definite covariance function (or kernel) that is assumed to
have a finite integral operator with eigenfunctions {φ`}∞`=1 and eigenvalues {δ`}∞`=1. Namely,∫
k(x,x′)d(x,x′) <∞, δ`φ`(x) =
∫
X
k(x,x′)φ`(x′) dx′.
For these classes of covariance functions, the following infinite expansion holds k(x,x′) =
∑∞
`=1 δ`φ`(x)φ`(x
′)
[29], and an RKHS function space may be formally defined via the closure of a linear combination of basis
functions [30]. As a direct result, we rewrite equation Equation (1) as the following RKHS regression
model [28]
y = Ψᵀc + ε, ε ∼ N (0, τ2I), (2)
where ψ(x) = {√δ`φ`(x)}∞`=1 is a vector space spanned by the bases, Ψ = [ψ(x1), . . . ,ψ(xn)]ᵀ is a
corresponding matrix of concatenated basis functions, and c = {c`}∞`=1 are the corresponding basis
coefficients. The above specification in Equation (2) closely resembles the linear model in Equation (1)
— except now the bases are the feature vectors ψ(x) (rather than the unit basis), and the transformed
space can be infinite-dimensional. Theoretically, this is an important property because the inclusion of
nonlinear interactions and covarying relationships are implicitly captured in the RKHS.
Unfortunately, properly representing any given basis function in an empirically amenable form is a
difficult task [31]. To circumvent this analytical issue, one may alternatively conduct inference in an
RKHS by specifying a Gaussian process (GP) as the prior distribution over the function space directly
f(x) ∼ GP(m(x), k(x,x′)),
where f(•) is completely specified by its mean function and positive definite covariance (kernel) function,
m(•) and k(•, •), respectively. In practice, if we condition on a finite set of locations (i.e. the set of
4observed samples n), the Gaussian process prior then becomes a multivariate normal [32]. By specifying
a joint version of the nonparametric regression model above, we consider taking a “weight-space” view
on Gaussian processes [6],
y = f + ε, f ∼ N (0,K), ε ∼ N (0, τ2I), (3)
where, in addition to previous notation, f = [f(x1), . . . , f(xn)]
ᵀ is assumed to come from a multivariate
normal with mean 0 and covariance matrix K = ΨᵀΨ with each element kij = k(xi,xj). Altogether,
we refer to the family of models taking on this form as GP regression. The formulation of the weight
space GP is similar to the linear mixed model (LMM) [33,34] that is frequently used in genetics but with
one key difference: the GP model utilizes a nonlinear covariance matrix K instead of the usual gram
matrix XXᵀ/p. From this perspective, an RKHS model can be viewed as an extension of the LMM for
modeling nonlinear effects such as statistical interactions. Indeed, the GP model still presents the same
modeling benefits as an LMM, such as controlling for structured random effects. For example, notice
that the Gaussian covariance function can written as a product of three terms [1]
exp
{
− 1
2θ2
‖x− x′‖2
}
= exp
{
− 1
2θ2
(‖x‖2 + ‖x′‖2)} exp{− 1
2θ2
xᵀx′
}
.
The last term includes (nonlinear transformed) elements of the LMM relatedness matrix that has been
well known to effectively control for population stratification in genetic studies [35–38]. Because of these
properties, RKHS-based models have become powerful tools for predictive problems in many research
areas, and have been widely used for genomic selection in animal breeding programs [39,40]. We replicate
some of these sentiments via a small simulation study (see Supplementary Text and Table S1).
Lastly, we want to point out that (although not explicitly considered here) the formulation of the GP
regression model in Equation (3) can also be easily extended to accommodate other fixed effects (e.g. age,
sex, or genotype principal components) [39,41], as well as be adapted to account for interactions between
variants and non-genetic risk factors [42,43].
Note on Bandwidth Parameters. In many cases, the covariance function is indexed by a band-
width parameter θ (also known as a smoothing parameter or lengthscale) — which we expansively write
as kθ(•, •). For example, the previously mentioned Gaussian kernel can be specified as kθ(x,x′) =
exp{−.5‖x − x′‖2/θ2}. Within a fully Bayesian model, this bandwidth parameter can be assigned a
prior distribution and its posterior distribution may be inferred [28]. However for simplicity, we fol-
low recent studies using the “median heuristic” and work with a fixed bandwidth that we choose as
θ = medianij‖xi − xj‖2 [44].
Posterior Inference and Sampling. We now briefly detail a simple Markov chain Monte Carlo
(MCMC) sampling procedure for estimating the parameters in GP regression. Assume now that we have
a completely specified hierarchical model
y = f + ε, f ∼ N (0,K), ε ∼ N (0, τ2I), τ2 ∼ Scale-Inv-χ2(a, b)
where, in addition to previous notation, we further assume that the residual variance parameter τ2 follows
a scaled-inverse chi-square distribution with degrees of freedom a and scale b as hyper-parameters. Given
the conjugacy of this model specification, we may use a Gibbs sampler to estimate the joint posterior
distribution P(f , τ2|y). This consists of iterating between the following two conditional densities:
1. f | τ2,y ∼ N (m∗,V∗) where m∗ = K(K + τ2I)−1y and V∗ = K−K(K + τ2I)−1K;
2. τ2 | f ,y ∼ Scale-Inv-χ2(a∗, b∗) where a∗ = a+ n and b∗ = a∗−1[ab+ (y − f)ᵀ(y − f)].
5Iterating the above procedure T times results in a set of sampled draws from the target joint posterior
distribution. Taking the mean over these draws yields posterior estimates for the model parameters (see
Supplementary Material for a detailed algorithmic overview).
2.2 Effect Size Analog for Nonparametric Methods
A noteworthy downside to the GP regression model is the inability to find an effect size for causal vari-
ants. From a prediction and genomic selection perspective this loss is fine — but from the perspective of
finding genetic markers that give rise to this improved predictive performance (i.e. association mapping),
the interpretability of the model is lost. We now define the effect size analog for general nonparametric
methods as a solution to this limitation [27]. We first briefly outline the conventional wisdom for coef-
ficients in linear regression. In linear models, a natural interpretation of a regression coefficient is the
projection of the genotypes X onto the phenotypic vector y,
β̂ = Proj(X,y), (4)
with the choice of loss function, noise model, as well as prior distributions or regularization penalties,
specifying the exact form of the projection. One standard projection operation is Proj(X,y) = X†y,
where X† is the Moore-Penrose generalized inverse. For Bayesian procedures, priors over the parameters
β induce a distribution on the resulting projection procedure Proj(X,y) [11,45].
The general definition for the effect size analog is based on the similar idea of projecting a nonlinear
function onto the design matrix. Specifically, consider a nonlinear function evaluated on n-observed
samples, such that E(y |X) = f . We formally define the effect size analog as the result of projecting the
genotypic matrix X onto the nonlinearly estimated function vector f ,
β˜ = Proj(X, f). (5)
This projection operation, and its practical calculation, effectively requires two sets of coefficients: (i)
the theoretical coefficients c on the basis functions; and (ii) the coefficients that determine the effect size
analog β˜. Following the formulation in Equation (5), we use Equations (2) and (3) to specify the joint
projection of design matrix X onto the vector f = Ψᵀc as the linear map,
β˜ = X†Ψᵀc = X†f . (6)
The argument for why the p-dimensional vector β˜ is an effect size analog for nonparametric regression
models is that, on the n-observations, f ≈ Xβ˜. In Supplementary Material, we re-derive previous results
to formally show that the map from f to β˜ is injective modulo the null space of the genotypic matrix [27].
This is similar to the classical linear regression case where two different coefficient vectors will result in
the same estimated value if the difference between the vectors is in the null space of X. Additionally, the
only requirement for Equation (6) is a well-defined feature map ψ(•). This includes taking the Cholesky
decomposition of the covariance matrix as a feature map, or even employing low-rank approximations
such as the Nystrom approximation [46], random Fourier features [47], or explicit Mercer expansions [48].
We should be clear that a variety of projection procedures (corresponding to various priors and loss
functions) can be specified, and a systematic study elucidating which projections are efficient and robust
is of interest for future research.
A key motivation for the effect size analog is to conduct nonlinear association mapping in the original
genotype space, while also accounting for population structure and significant covarying relationships
between variants. When a phenotype or trait is solely driven by additive effects, the projections (4) and
(5) with the same genotypes X are equivalent, and the resulting effect size analog from Equation (6) is
the same as the OLS estimate derived by a standard linear model. Alternatively, it has been shown (via
6Taylor series expansions) that certain covariance functions enumerate nonlinear effects among observed
markers [49]. The Gaussian kernel, in particular, includes all higher-order interaction components, where
the contribution of the terms decays polynomially with the order of nonlinearity [1]. Therefore, when a
given phenotype is driven by an arbitrary combination of additivity and interactions, a properly chosen
nonlinear map ψ(•) will lead to an inversion in Equation (6) that represents each β˜j as a weighted sum of
higher order interactions between marker j and all other markers (see text in Supplementary Material).
3 Genetic Association Mapping using Centrality Measures
The effect size analog serves as a nonlinear summary coefficient for each genetic variant in the original
modeling space. However, since the explicit projection in Equation (6) does not always guarantee a
preserved mapping of sparse solutions [27], we cannot directly use standard Bayesian quantities such
as posterior inclusion probabilities (PIPs) or Bayes factors (BFs) to rank markers in order of their
significance. Indeed, there are many approaches to compute marginal association statistics based on
corresponding effect size estimates [3, 50], but many of these techniques rely on arbitrary thresholding.
More importantly, they also fail to take advantage of significant underlying dependencies and covarying
relationships between variants or sets of genomic loci.
We now develop our main methodological innovation. We introduce an analogy to traditional Bayesian
hypothesis testing for nonparametric regression methods: a post-hoc approach for association mapping
via a series of “distributional centrality measures” using Kullback-Leibler divergence (KLD) [10, 51–56].
Our strategy will be to use the posterior samples of the effect size analogs to infer the relative covariance
between genetic variants. This underlying correlation structure will then be systematically searched
over to posit significant individual associations. We refer to this approach as computing the “RelATive
cEntrality” of genetic markers, or RATE.
3.1 Kullback-Leibler Divergence
Typical questions in network studies simplify to the general issue of determining the “centrality” of nodes
— the potential importance of individual components in relation to the other nodes in the entire network.
When network relationships are modeled via multivariate distributions, this can be explored in various
statistical ways. Assume here that we have a collection of deterministically computed samples from
the implied posterior distribution of the effect size analog β˜ (via the projection in Equation (6)). One
interpretable way to summarize (in a single measure) the influence/importance of the j-th variant in xj ,
on the rest of the variants in X−j , is via the computation of the KLD measuring the difference between
P(β˜−j | β˜j) and P(β˜−j). Specifically, this is defined by solving the following integral
KLD(β˜j) =
∫
β˜−j
log
(
P(β˜−j)
P(β˜−j | β˜j)
)
P(β˜−j) dβ˜−j , j = 1, . . . , p, (7)
where we use the shorthand KLD(β˜j) = KLD(P(β˜−j)‖P(β˜−j | β˜j)). Here, the KLD is a non-negative
quantity and, in this context, takes the value of zero if and only if P(β˜−j | β˜j) = P(β˜−j). Equivalently,
this means that the KLD is zero if and only if the posterior distribution of β˜−j is independent of the
effect β˜j . Therefore, the case for which KLD(β˜j) = 0 may simply be interpreted as meaning that variant
j is not a key explanatory variable relative to others. Otherwise, for any given conditioning value β˜j , the
divergence in Equation (7) represents the information (i.e. entropy) change induced on the distribution
of β˜−j — naturally varying as the conditioning value β˜j varies.
7Closed Form Derivation under Approximate Normal Posteriors. For our case study and imme-
diate applications, we are interested in straightforward computation of KLD measures in order to address
problems with increasingly large numbers of genotypes and possible interactions. For these purposes,
and the rest of the paper, we therefore restrict attention to contexts in which we can assume an adequate
normal approximation to the full joint posterior distribution of the p-dimensional effect size analog β˜.
Ongoing and future work is concerned with computational and numerical aspects of the more general
context, while the methodological and applied advances enabled by our approach are well-highlighted
under the normal posterior assumption.
Thus, we take the posterior for β˜ as (approximately) multivariate normal with an empirical mean
vector µ and positive semi-definite covariance/precision matrices Σ = Λ−1 estimated via simulation
methods. Consider the association mapping case where we want to investigate the centrality or marginal
importance of marker j. We may partition conformably as follows
β˜ =
(
β˜j
β˜−j
)
, µ =
(
µj
µ−j
)
, Σ =
(
σj σ
ᵀ
−j
σ−j Σ−j
)
, Λ =
(
λj λ
ᵀ
−j
λ−j Λ−j
)
,
where β˜j , µj , σj and λj are scalars; β˜−j , µ−j , σ−j , and λ−j are (p − 1)-dimensional vectors; and Σ−j
and Λ−j are (p − 1) × (p − 1) positive definite, symmetric matrices. Under this partitioning, we know
that the marginally β˜−j ∼ N (µ−j ,Σ−j). Furthermore, we also know that, when conditioned on the j-th
variant, P(β˜−j | β˜j) is a multivariate distribution with expectation and covariance
E(β˜−j | β˜j) = µ−j + θj(β˜j − µj), V(β˜−j | β˜j) = Λ−1−j ,
where θj = −Λ−1−jλ−j is a (p − 1)-dimensional vector. Inserting these probability density forms into
Equation (7), with some algebraic rearrangement, yields the following
KLD(β˜j) =
1
2
[−log|Σ−jΛ−j |+ E(eᵀ−jΛ−je−j)− 2E(eᵀ−j)Λ−jθjej − E(eᵀ−jΣ−1−je−j) + e2jθᵀjΛ−jθj] (8)
where log|•| represents the log determinant function of a matrix, e−j = β˜−j−µ−j is a vector, ej = β˜j−µj
is a scalar, and the expectations are taken with respect to the marginal posterior distribution of β˜−j .
Next, denote the following definition of an expectation of quadratic forms [57],
E(uᵀQu) = E(uᵀ)QE(u) + tr(V(u)Q),
for any vector u and positive semi-definite covariance matrix Q, where tr(•) is the matrix trace function.
Using this equality, the computation of the KLD in Equation (8) simplifies to the following closed form
KLD(β˜j) =
1
2
[
−log(|Σ−jΛ−j |) + tr(Σ−jΛ−j) + 1− p+ αj(β˜j − µj)2
]
, (9)
where αj = θ
ᵀ
jΛ−jθj = λ
ᵀ
−jΛ
−1
−jλ−j and tr(I) = p − 1. By symmetry in the notation for elements of
sub-vectors and sub-matrices, it trivially follows that we may simply permute the order of the variables
in β˜ and iteratively compute the KLD to measure the centrality of any variant j.
3.2 Prioritization and Relative Significance
In the nonlinear regression context, values β˜j close to zero may be interpreted as “null hypotheses” with
little to no relevance to the modeled outcome. Therefore, searching for the most central (i.e. influential)
genetic markers simply reduces to looking for the greatest KLD when setting each β˜j = 0. More con-
8textually specific questions arise when deciding if a given centrality measure is significant. Indeed, in
practice, a threshold may be chosen in order to determine if any given KLD represents a significant shift
in entropy. Previous studies have done this through k-fold permutation to find an effective genome-wide
threshold [53]. This approach can be costly for datasets with many markers.
A more computationally efficient option for determining a natural ranked cutoff is to explore the
relevance of variables recursively, and judge their significance via a scaled version of the KLD. We call
this “RelATive cEntrality” or RATE,
RATE(β˜j) = KLD(β˜j)/
∑
KLD(β˜`),
∑
RATE(β˜j) = 1. (10)
Here, the RATE measure is bounded within the range [0, 1], with the natural interpretation of measuring
a variable’s relative importance. Suppose that j identifies the genetic marker with the largest RATE
value. Conditioning on a reduced margin, and then repeating the computation outlined in Equations (9)
and (10), will identify the relatively second most explanatory marker. We can repeat this procedure until
each of the remaining variants appear to be equal in their relative importance. This would indicate that
all significant variants had been identified, and all that remain are variants for which their influences on
the posterior distribution are indistinguishable. This recursive process can be simplified to defining an
initial set of candidate associated markers with first order centrality measures satisfying{
j : RATE(β˜j) > 1/p
}
.
The value 1/p represents the null assumption that there is relatively equal importance across all variants;
and hence, there are no central nodes that exist within the posterior distribution. We may quantify
this behavior by checking the entropic difference between a uniform distribution and the observed RATE
measures. Namely,
∆ = log(p)−H, H = −
∑
RATE(β˜j)log(RATE(β˜j)), (11)
where H represents the intrinsic entropy of the relative centrality measures, and the case of no significantly
associated markers yields an entropy of log(p). One way to calibrate ∆ is linked to effective sample size
(ESS) measures from importance sampling [58, 59]. In a very different applied context, authors have
exploited the use of an approximate ESS measure defined by
ESS = 1/(1 + ∆)× 100%. (12)
This ESS measure is a calibration metric that provides a notion of “loss in uniformity”. For example,
50% loss in terms of (1-ESS) translates to a larger ∆ value of 1. This equates to the presence of at least
one variant that is significantly associated with the observed phenotypic trait. On the other hand, a
minor 5% loss corresponds to a more uniform case with ∆ value of about 0.05. Again, this latter scenario
would occur when there are hardly any influential markers within the data.
For any given set of significant variables, according to their estimated RATE measure, further analyses
may be carried out involving the relative costs of false positives and negatives to make an explicitly
reasoned decision about which specific variants to pursue [50]. Unless stated otherwise, the results we
present throughout the rest of the paper will be based on using RATE. We explore the power of this
alternative approach for association mapping in Section 4.
3.3 Relationship to Graphical Models and Precision Analysis
In conventional statistics, the proposed variable selection procedure is very much related to precision
analysis. It follows that the rate of change for the KLD (i.e. the first derivative of Equation (9) with
9respect to a given effect size analog), is found via the term αj = λ
ᵀ
−jΛ
−1
−jλ−j . This means that the closed
form computation of the KLD is directly impacted by the deviations between the approximation of a given
predictor’s posterior mean and the assumption that its true effect is zero. Therefore, αj characterizes the
implied linear rate of change of information when the effect of any predictor is absent — thus, providing
a natural (non-negative) numerical summary of the role of β˜j in the multivariate distribution. In terms
of weightings from the precision matrix, we see the following equivalent representation for the rate of
change of the KLD,
αj =
∑
k 6=j
∑
` 6=j
ck`λjkλj`,
where ck` is the corresponding k-`-th element of the matrix Λ
−1
−j . As derived in the previous subsection,
we may alternatively denote αj = θ
ᵀ
−jΛ−jθ−j , where again θ−j = −Λ−1−jλ−j is a (p − 1)-dimensional
vector and Λ−j is the precision matrix of the conditional distribution P(β˜−j | β˜j). These representations
help show that, in the context of normal statistical regression, αj computes the “variance explained”
(i.e. the fitted sum-of-squares) by each covariate j.
The idea of variable selection via entropic shifts also has a key connection to graphical models.
Often the goal of graphical models is to investigate if the precision matrix has some off-diagonal series
corresponding to an underlying conditional independence structure between predictor [60]. RATE — a
relative distributional centrality measure that assesses importance (or influence) of each variable on the
network of relationships reflected in the graph — is greatly affected by the graphical structure resulting
from the implied zeros in Λ. A missing edge between two predictors j and ` means that λj` = 0; hence,
limiting the contribution of node ` to the overall “network impact factor” of αj . From the sum defining
αj above, we see that a term related to variables k and ` is non-zero only when both λjk and λj` are
non-zero. Therefore, the k-`-th summation term is non-zero only for pairs of predictors that are direct
neighbors of j in an undirected graph.
3.4 Software Implementation
Software for computing the RATE measure is carried out in R code, which is freely available at https://
github.com/lorinanthony/RATE. Detailed derivations of the algorithm, which utilizes low-rank matrix
factorizations for a more practical implementation, are derived in Supplementary Material.
4 Results
We now illustrate the utility of using centrality measures for genetic association mapping through ex-
tensive simulation studies and real data analyses. The motivation for each set of examples is to better
understand the performance and behavior of RATE under different types of genetic architectures. First,
we use a small simulation study to help the reader build a stronger intuition about how RATE prioritizes
influential variables in a dataset. It is during this demonstration where we also explore what happens
to the concept of “centrality” and “uniformity” when the effects of all known significant markers are
assumed to be absent from the model. Next, we use more realistic simulations to assess the mapping
power of our approach in genetic based applications. Here, the goal is to show that RATE performs as-
sociation mapping as well as the most commonly used Bayesian and regularization modeling techniques.
Finally, we assess the potential of the our approach in two real datasets. The first is an Arabidopsis
thaliana QTL mapping study consisting of six different metabolic traits from an F6 Bay-0 × Shahdara
recombinant inbred lines (RILs) population. The second is a genome-wide association study (GWAS) in
a heterogeneous stock of mice from the Wellcome Trust Centre for Human Genetics.
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4.1 Simulation Studies
For all synthetic demonstrations and assessments, we consider a simulation design that is often used to
explore the utility of statistical methods across different genetic architectures underlying complex pheno-
typic traits [18,19,61]. First, we assume that all of the observed genetic effects explain a fixed proportion
of the total phenotypic variance. This proportion is referred to as the “broad-sense heritability” of the
trait, which we denote as H2. From the more conventional statistics perspective, the parameter H2 can
alternatively be described as a factor controlling the signal-to-noise ratio in the simulations. Next, we
use a genotypic matrix X with n samples and p single nucleotide polymorphisms (SNPs) to generate
synthetic real-valued phenotypes that mirror genetic architectures affected by a combination of linear
(additive) and interaction (epistatic) effects.
We randomly choose a select subset of j∗ “causal” (or truly associated) SNPs as the determining
factors of the data generating process. The linear effect sizes for all j∗ associated genetic variants are
assumed to come from a standard normal distribution: βj∗ ∼ N (0, 1). When applicable, we also create a
separate matrix W which holds all pairwise interactions between the causal SNPs. These corresponding
interaction effect sizes are drawn as γ ∼ N (0, I). We scale both the additive and interaction effects so
that collectively they explain a fixed proportion of H2. Namely, the additive effects make up ρ%, while
the pairwise interactions make up the remaining (1−ρ)%. Alternatively, the proportion of the heritability
explained by additivity is said to be V(Xβ) = ρH2, while the proportion detailed by nonlinearity is given
as V(Wγ) = (1 − ρ)H2. We consider two choices for the parameter ρ = {0.5, 1}. Intuitively, ρ = 1
represents the limiting case where the variation of a trait is driven by solely additive effects. For ρ = 0.5,
the additive and interaction effects are assumed to equally contribute to the total phenotypic variance.
Once we obtain the final effect sizes for all causal variants, we draw normally distributed random errors
as ε ∼ N (0, I) to make up the remaining (1 − H2)% of the total V(y). Finally, continuous phenotypes
are then created by summing over all observed effects using two simulation models:
(i) Standard Model: y = Xβ + Wγ + ε
(ii) Population Stratification Model: y = Zω + Xβ + Wγ + ε
where Z contains covariates representing additional population structure, and ω are the corresponding
fixed effects which are also assumed to follow a standard multivariate normal distribution. Alternatively,
one can think of the combined effect of Zω as structured noise. To this end, simulations under model
(ii) will make the appropriate assumption that V(Zω) +V(ε) = (1−H2). For any simulations conducted
under model (ii), genotype PCs are not included in any of the model fitting procedures, and no other
preprocessing normalizations were carried out to account for the added population structure.
It is helpful to point out here that the main purpose of the following simulations is to demonstrate the
utility of RATE in providing an explicit ranking of variable importance — so as to uncover the implicit
ranking assigned by nonparametric regression methods. Our simulation comparisons are thus targeted to
illustrate how RATE can be used in this task, and how its overall variable selection performance differs
from standard parametric mapping procedures in different scenarios.
4.1.1 Proof of Concept Simulations: Demonstrating Centrality
In this subsection, we show how distributional centrality measures may be used and interpreted when
prioritizing genetic markers in an association mapping study. Our main concern is to familiarize the
reader with the behavior and concepts underlying RATE. To do this, we make use of n = 2000 synthetic
genotypes that are independently generated to have p = 25 single nucleotide polymorphisms (SNPs) with
allele frequencies randomly sampled from a uniform distribution over values ranging from [0.05, 0.5]. The
resulting n × p simulated genotype matrix X is then used to create continuous phenotypes using the
standard generative model (i). Here, we assume that only the last three variants j∗ = {23, 24, 25} are
causal, and that their combined genetic effects make up a moderate H2 = 60% of the total phenotypic
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variation. We then examine the full two cases for the parameter ρ = {0.5, 1}. As a brief reminder, ρ
represents the proportion of broad-sense heritability that is contributed by additivity versus interaction
effects. Indeed, these simulation assumptions are not realistic in terms of the qualities observed in
real data applications; however, we stress that this section merely serves as a simple demonstration of
“centrality” and “uniformity.” The small number of variants allows us to clearly illustrate and visualize
these proofs of concepts.
Throughout the rest of this subsection, we detail the behavior RATE in the simple linear case with
ρ = 1. Similar results for ρ = 0.5 can be found in Supplementary Material. For each simulation, we
fit a standard GP regression model under a zero mean prior and a Gaussian covariance function using a
Gibbs sampler with 10,000 MCMC iterations and hyper-parameters set to a = 5 and b = 2/5. During
each iterate, a corresponding nonlinear projection is computed as in Equation (5). This results in an
approximation of the implied posterior distribution for the effect size analog. With these conditional
draws, we calculate the distribution’s empirical posterior mean, covariance, and precision. Next, we use
the closed form solutions in Equations (9) and (10) to derive a RATE measure for each genetic marker.
Figure 1(a) depicts an illustration of first order centrality across the 25 variants. Here, the three known
causal SNPs are colored in blue. As a reference, we also display a red dashed line that is drawn at the
level of relative equivalence (i.e. 1/p). This represents the value for which all variants are approximately
uniform in their centrality or significance. To put this into better context, we provide uniformity checks:
(i) the entropic difference ∆ according to Equation (11), and (ii) the corresponding empirical ESS estimate
as computed in Equation (12). In this first panel figure, we see that RATE accurately determines variants
#23-25 as being the most central to the posterior distribution.
To demonstrate what it conceptually means to be central to a distribution, we next consider a se-
ries of follow-up analyses. Here, we iteratively assume that the genetic effect of the most significantly
associated SNP has been nullified from the dataset. We then condition on a reduced margin for the
posterior distribution and recompute the RATE measures. The key takeaway is that, without the effect
of the data’s most influential SNPs, the relative importance of the remaining variants will continue to
increase until each of them are approximately equal in weight — hence, resembling a uniform distribution.
Consider the ongoing example, and assume that we nullify the effect of variant #24. After recomputing
RATE(β˜j | β˜24 = 0) for every j 6= 24-th variant, we see that while markers #25 and #23 are still the
most significant according to their second order centrality, the importance levels of the other markers
have shifted closer to becoming relatively equivalent (see Figure 1(b)). This shift continues when the
effects of the remaining causal variants are also removed successively (see Figures 1(c) and 1(d), respec-
tively). Also notice during this transition, ∆ → 0 and ESS → 100%. This same trend happens both in
the presence of interaction effects (Figure S2), as well as when the causal variants are in nearly perfect
collinearity (or “linkage disequilibrium”, LD) with non-causal markers (Figures S3 and S4). In the latter
case, we force variants #23-25 to have a correlation coefficient R = 0.9 with variants #1-3.
It is also important to demonstrate happens to the proposed centrality measures if one mistakenly
removes the effect of a genetic marker that is not central to explaining the observed phenotypic variation.
Reconsider the ongoing example where, instead of iteratively removing the effect of the most central
variant, we simply nullify the effect of markers #1-3 which we know to be nonsignificant (see Figure
2(a)). Figures 2(b)-2(d) (and Figure S5) illustrate that the three true causal variants (i.e. markers #23-
25) are continuously identified as the most associated or central to the overall posterior distribution.
Noticeably, with each passing removal of a non-central variant, the degree to which the RATE measures
begin to look uniform has slowed substantially.
As a final demonstration, we show what happens when the null assumptions of relative centrality are
met. Recall that, under the null hypothesis, RATE assumes that every variant equally contributes to
the broad-sense heritability of a trait — that is, no one SNP is more important or more central than the
others. To illustrate this, we generate synthetic phenotypes such that the effect sizes of all twenty-five
SNPs in the data are set to 1. Figure S6 shows results from four different datasets. The key takeaway here
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is that, in these cases, RATE produces much more uniformly distributed first order centrality measures
as indicated by the entropic statistics ∆ and ESS. For completeness, in Figure S7, we also show what
happens to the raw and unscaled KLDs when phenotypes have been permuted.
4.1.2 Power Assessment and Method Comparisons
We now assess the power of RATE and its ability to effectively prioritize truly associated variants under
different genetic architectures. To do this, we now consider simulations that mirror more realistic genetic
applications. Here, we utilize real genotypes from chromosome 22 of the control samples in the Well-
come Trust Case Control Consortium (WTCCC) 1 study [62] (http://www.wtccc.org.uk/) to generate
continuous phenotypes (see Supplementary Material for details). Exclusively considering this group of
individuals and SNPs leaves us with an initial dataset consisting of n = 2,938 samples and p = 5,747
markers. During each simulation run, we randomly choose j∗ = 30 SNPs which we classify into the
two distinct causal groups: (1) a small set of 5 variants, and (2) a larger set of 25 variants. All causal
markers have additive effects and, when applicable, the group 1 causal SNPs interact with group 2 causal
SNPs, but never with each other (the same rule applies to the second group). We will consider three
simulation scenarios. Scenario I involves phenotypes generated by standard model (i); while scenarios
II and III consider model (ii) where we introduce population stratification effects by allowing the top 5
and 10 genotype principal components (PCs) Z to make up 30% of the overall variation in the simulated
traits, respectively. Within these three scenarios, we set the broad-sense heritability to be H2 = 0.3 and
consider two choices for the parameter ρ = {0.5, 1}.
We compare the GP regression model and our proposed distributional centrality measures to a list
of standard Bayesian and regularization modeling techniques. Specifically, these methods include: (a)
a genome scan with a single-SNP univariate linear model that is typically used in GWAS applications
(SCANONE) [63] (b) L1-regularized lasso regression; (c) the combined regularization utilized by the
elastic net [64]; and (d) a commonly used spike and slab prior model, also commonly known as Bayesian
variable selection regression [65], which places a prior distribution on each SNP as a mixture of a point
mass at zero and a diffuse normal centered around zero. For each Bayesian method, we run a Gibbs sam-
pler for 10,000 MCMC iterations. Regularization approaches were fit by first learning tuning parameter
values via 10-fold cross validation.
All results described in the main text are based on scenarios I and II, while results for scenario III
be found in Supplementary Material. We evaluate each method’s ability to effectively prioritize the
causal SNPs in 100 different simulated datasets. The criteria we use compares the false positive rate
(FPR) with the rate at which true variants are identified by each model (TPR). This is further quantified
by assessing the area under the curve (AUC). Note that SCANONE produces p-values, lasso and the
elastic net give magnitude of regression coefficients, and the Bayesian variable selection model computes
posterior inclusion probabilities (PIPs). Method performance varies depending on the two factors: (a) the
presence of interaction effects, and (b) additional structure due to population stratification. For example,
in the first simulation scenario, all methods exhibit lower power when a proportion of the broad-sense
heritability is made up of interaction effects (e.g. Figure 3(a)). This power increases when additive effects
dominate the heritability (e.g. Figure 3(b)). Overall, the lasso is the worst performing method. In the
cases where there are no additional population stratification effects, the SCANONE approach proved to
be better method. These results are unsurprising since this scenario best suites the assumptions of this
approach.
While the performance of our distributional centrality measures are comparable in the first setting,
its true advantage becomes apparent when there is some underlying population structure between geno-
types (i.e. scenarios II and III). Importantly, under this type of data, the power of RATE is consistently
better than its counterparts (e.g. Figures 3(c), 3(d), and S8). From a significance threshold perspec-
tive, RATE also proves to have the best “optimal” selection metric. Solely considering SNPs with
RATEs > 1/p consistently yielded more associative mapping power than observing both (a) the equiv-
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alence of the Bayesian “median probability model” (i.e. PIPs > 0.5) [3], and (b) SCANONE p-values
below the Bonferroni-corrected significance threshold (i.e. P < 8.7× 10−6) (see Figure S9). For example,
in simulation scenario II, the “optimal” RATE model identified 72% and 78% of the casual variables for
ρ = 0.5 and 1, respectively. This compared to 24% and 37% for the median probability model, and 32%
and 46% for the multiple testing corrected SCANONE model (see Figure S9). This trend is consistent
across all of the simulation settings that we consider.
Altogether, we want to stress that these simulation results are important from a model interpretation
perspective. Even though methods like SCANONE effectively prioritize SNPs in certain scenarios, their
significance metrics struggle to create separation between selected and non-selected markers. Therefore,
if a practitioner were to choose variants satisfying some “optimal” genome-wide threshold, the more
conservative methods will simply miss the majority of the true causal variables (i.e. a higher count of
false negatives). RATE, on the other hand, is consistently able to distinguish among the SNPs in a
given set. Even in the scenarios where phenotypes are simulated without population stratification effects,
RATE is more likely to deem associated variants as significant genome-wide — just at the possible cost
of slightly more false positives.
4.2 Real Data Analysis: Arabidopsis QTL Study
We now apply our approach to a quantitative trait loci (QTL) association mapping study focused on
the characterization of complex phenotypes in Arabidopsis thaliana, a small flowering plant native to
Eurasia. The specific dataset that we consider comes from the Versailles Arabidopsis Stock Center [66]
(http://publiclines.versailles.inra.fr/page/33) and has been previously used for evaluating the
mapping power of other statistical methods [67]. More descriptively, it consists of n = 403 F6 plants from
a Bay-0 × Shahdara recombinant inbred lines (RILs) population that were genotyped for p = 1028 genetic
markers and phenotyped for sixty-three different metabolic traits [68]. After pruning the genotypes of
variants with near perfect correlation (R ≥ 0.99), we obtained a final set of 524 markers (see Supplemen-
tary Material for details). We limit the scope of our analysis to six biochemical content measurements
including: allyl, Indol-3-ylmethyl (I3M), 4-methoxy-indol-3-ylmethyl (MO4I3M), 4-methylsulfinylbutyl
(MSO4), 8-methylthiooctyl (MT8), and 3-hydroxypropyl (OHP3) (see Table S2). Importantly, the goal
of the original study was to highlight complex connections between gene expression and metabolite (glu-
cosinolate) variation [68]. Here, we consider this particular case study not only because it presents a
variety of quantitative traits, but also because the data contains a mixture of additive and some epistatic
effects. Indeed, this dataset presents a realistic mix between the cases we previously examined for simu-
lation scenario I.
For each metabolic trait, we provide a summary table which lists centrality measures for all gene
expression polymorphisms as detected via GP regression and RATE (see Table S3). To contrast the
associations identified by our nonparametric method, we also directly compared results from implementing
the SCANONE approach since it proved to be the most powered of the competing methods in simulations
(again see Table S3). Figures 4 and S10-S14 display plots of enrichment for a genome-wide scan on the
six traits according to the RATE enrichment metric. These figures also show the comparative results for
the standard single-variant testing approach. Referenced in all images are blue points which represent
genetic markers with significant distributional centrality measures above the line of relative equivalence
(i.e. RATEs > 1/p). In Table 1, we report the number of significant markers that are identified by
both methods. Once again, these are determined by markers with RATE(β˜) > 1/p and P < 9 × 10−5,
respectively. Again, the latter represents the genome-wide Bonferroni-corrected significance threshold.
In the second part of Table 1, we take the significant markers identified by each model and refit simple
linear regressions with them. Here, we report R2 as a way to assess which method was able to select
markers that explain the greatest proportion of variance in all six traits.
Overall, RATE consistently identified genomic locations that correspond to known members of biosyn-
thetic pathways in Arabidopsis thaliana. Most of these, as in the original study, were small networks of
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QTLs known to control biosynthetic pathways. For example, in MO4I3M, the most central loci appeared
on the second chromosome and were headlined by the marker tagged At2g14170 (see Figure 4(a)). This
variant is associated with ALDH6B2 — a gene within the Arabidopsis genome known to catalyze enzy-
matic reactions in valine and pyrimidine catabolism (i.e. destructive metabolism) [69, 70]. Similarly, on
the first chromosome, RATE featured a small group of central loci lead by At1g78370 — which encodes a
core glucosinolate biosynthesis gene GSTU20 and plays a key role in glutathione transferase activity and
metabolism [71]. For the trait MT8 content, RATE deemed the most important region of the genome
to be on the fifth chromosome (see Figure S13). Here, the marker At5g22630 had the greatest relative
centrality measure. This polymorphism represents ADT5 which has recently been suggested to moonlight
proteins that play an enzymatic role in biosynthesis [72]. This same marker is also highlighted as being
moderately influential in explaining the variability in allyl content across the plants (see Figure S10).
This makes sense because of the strong positive correlation between the content of these two traits.
These validated findings from previous experimentally based studies lead us to believe that our results
contain true positives. Lastly, in order to bolster confidence in the relative centrality measures identi-
fied by our nonparametric approach, we also display the correlation structure across the genotypes and
phenotypes for the 403 Bay-0 × Shahdara RILs (see Figures S15 and S16). Consistent with our results,
there appeared to be strong cis-type covariances between groups of genetic markers located on the same
chromosome. This underlying genetic architecture resembles data analytic situations where our approach
is most powered.
In order to better explain why our nonparametric approach and the SCANONE method performed
similarly in each of the six phenotypes, we use a variance component analysis to evaluate how different
types of genetic effects (i.e. linear vs. nonlinear) contribute to the overall broad-sense heritability [73] (see
text in Supplementary Material for details). Briefly, we use a linear mixed model with multiple random
effects to partition the phenotypic variance into three different categories: (a) an additive component,
(b) a pairwise interaction component, and (c) a third order interaction component. Disregarding the
contribution of random noise, we quantify the contribution of these genetic effects by estimating the
proportion of heritability that is explained via their corresponding variance components. Table S4 displays
these results which effectively highlights that each of the six traits are primarily dominated by additivity.
4.3 Real Data Analysis: Heterogenous Stock of Mice GWAS
We lastly assess RATE’s association mapping ability in a more traditional GWAS setting by analyzing
three quantitative traits in a heterogeneous stock of mice dataset [74] from the Wellcome Trust Centre
for Human Genetics (http://mtweb.cs.ucl.ac.uk/mus/www/mouse/index.shtml). This data contains
n ≈ 2, 000 individuals and p ≈ 10, 000 SNPs with minor allele frequencies above 5% — with exact
numbers varying slightly depending on the phenotype (see Supplementary Material for details). The
three quantitative traits we consider include: body weight, percentage of CD8+ cells, and high-density
lipoprotein (HDL) content. We consider this particular dataset not only because it contains a wide variety
of quantitative traits, but also because the data contains related samples. Relatedness has been shown
to manifest different orders of interaction effects [18,27,75], and thus this dataset also presents a realistic
mix between the cases we examined in simulation scenarios II and III.
Once again, we compare the GP regression model to the single-SNP approach via SCANONE, which
serves as a baseline. For each trait, we provide a summary table which lists the corresponding RATEs
and p-values for all SNPs (see Table S5). Figures 5, S17, and S18 then visually display this information
via Manhattan plots. In these figures, chromosomes are shown in alternating colors for clarity, with the
top five most enriched regions (according to RATE measures) being highlighted as a way to facilitate
comparisons between the mapping approaches.
As in the previous real data application, our nonparametric approach was able to detect multiple loci
that have been previously validated as having functional associations with the traits of interests. Many of
these findings were also indicated in the original study that produced this dataset [74]. For example, the
15
X chromosome is well known to majorly influence adiposity and metabolism in mice [76–79]. As expected,
in the body weight and HDL content traits, our approach identified significant enrichment in this genomic
region — headlined by the chromatin remodeling complex gene Smarca1 in both cases. Additionally, for
the body weight phenotype, RATE also prioritized markers on chromosomes 7 and 10 as having notable
associations. Previous computational studies have shown variants on both of these chromosomes to
have additive effects and statistical epistatic interactions that influence mice body composition [80–83].
In this particular analysis, we attribute the selection of these loci to the nonlinear properties of the
Gaussian covariance function and the nonparametric nature of the GP regression model. Similarly, for
HDL content, RATE found many significant SNPs on the first, eleventh and twelfth chromosomes. The
corresponding spike on chromosome 1 is a genomic location that most notably harbors the HDL driver
gene Ath-1 [84] (see Figure 5(a)). Finally, for the phenotype detailing the percentage of CD8+ cells, our
method identified the majority of significant SNPs to be on the seventeenth chromosome — including
those within boundary of Myof1, a gene that has been suggested to modulate cell adhesion and motility
in the immune system [85]. Overall, this general genomic location that has been validated to greatly
determine the ratio of T-cells [86].
Once again, we use variance component analysis to now dissect the broad-sense heritability of these
three mice traits and help better explain why there could be differences in the loci discovered by RATE
and SCANONE (see Table S6). As in the previous subsection, we implement a linear mixed model to
partition the overall broad-sense heritability into the same additive, second order (pairwise) interaction,
and third order interaction genetic effect types. Note that, unlike in the Arabidopsis QTL study, additive
effects do not dominate the genotypic contribution in any of the three mice phenotypes that we consider
— this is particularly obvious for the trait detailing the HDL content (Figure 5 and Table S6). Instead,
the variance components corresponding to the second and third order interactions make up the majority
of the broad-sense heritability. We believe that accounting for these nonlinear relationships, as well as
controlling for the relatedness between samples, allows RATE to identify loci that SCANONE misses.
5 Discussion
In this paper, we proposed a new general measure for conducting variable selection in “black box” Bayesian
methodologies. While many of these black box approaches often give notable predictive performance
gains, the reasoning behind these results can be difficult to explain and interpret. Within a statistical
genetics context, we discussed how the previously proposed effect size analog for nonparametric regression
enables the prioritization of variants based on their marginal associations. Recognizing that one of the
main sources of performance gains in black box modeling is through underlying interactions and nonlinear
effects between predictor variables, we introduced our new distributional centrality measure RATE —
meant to rank genetic markers based on their influence on the joint distribution with other markers.
As we demonstrated with simulation studies, our new measure can be used for feature selection, giving
state-of-the-art performance even in the presence of population structure. In real QTL and GWAS data
applications, RATE allowed us to uncover biologically relevant markers by simultaneously taking into
account significant interactions when ranking variants based on their relative importance.
In its current form, we have focused on demonstrating RATE with a Gaussian process regression
model. Although our entire illustration of the method is based on the manipulation of approximate
posterior distributions in Bayesian applications, each of the innovations that we present can be applied
in a frequentist setting. The effect size analog is merely a summary statistic which can be derived after
fitting any model. Therefore, one could envision a frequentist setting in which parameter estimation
and uncertainty is done using bootstrap, for example. In particular, this would lead to a multivariate
normal-like estimator for the mean and covariance of the effect size analog. One could then proceed to
compute the relative centrality measures with this distribution. The utility of our approach, from this
alternative point of view, remains an open question.
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RATE is not without its limitations. One particular limitation of RATE is that while it provides
a measure of general association for nonparametric methods, it cannot be used to directly identify the
component (i.e. linear vs. nonlinear) that drives individual variable associations. Thus, despite being able
to detect significant variants that are associated to a response in a nonlinear fashion, the RATE measure
is unable to directly identify the detailed orders of interaction effects. A key part of our future work
is learning how to disentangle this information. A second, and perhaps the most noticeable, limitation
of RATE is that the computation of the centrality measures scales at least cubically with the number
of features in the input data (see Table S7 in Supplementary Material). This is opposed to the other
methods we compare in this study (e.g. single-SNP tests) which take a fraction of the time to compute.
In future work, we would like to consider the challenges of analyzing large scale studies. An example of
this would be consortium-sized efforts in human-based genome-wide association studies with millions of
markers and thousands of genotyped individuals [62, 87, 88]. In these settings, one possible immediate
fix would be to use a two step procedure. In the first step, we implement a more scalable mapping
method [33,34,89] as a screen to select the top marginally associated markers. Then in the second step,
we test for more detailed nonlinear prioritization using centrality measures. Nonetheless, new algorithms
and alternative code implementations are likely needed to scale RATE up to datasets that are orders of
magnitude larger in size.
Supplementary Material
Supplementary Material is available for download at http://www.lcrawlab.com/Papers/RATE_SI.pdf.
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Figure 1. Orders of distributional centrality via RATE measures. These are simple proof of
concept simulations with broad-sense heritability level H2 = 0.6 and ρ = 1. Here, (1− ρ) is used to
determine the proportion of signal that is contributed by interaction effects. Data are simulated such
that the effects of only the last three genetic variants j∗ = {23, 24, 25} (blue) are nonzero. The dashed
line is drawn at the level of relative equivalence (i.e. 1/p). Figure (a) shows the first order centrality
across all markers; (b)-(d) show results when the most significantly associated variants are iteratively
nullified. Uniformity check values are also reported: (i) the entropic difference ∆, and (ii) the
corresponding empirical effective sample size (ESS) estimates.
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Figure 2. Orders of distributional centrality via RATE measures when non-associated
variants are deemed significant. These are simple proof of concept simulations with broad-sense
heritability level H2 = 0.6 and ρ = 1. Here, (1− ρ) is used to determine the proportion of signal that is
contributed by interaction effects. Data are simulated such that the effects of only the last three genetic
variants j∗ = {23, 24, 25} (blue) are nonzero. The dashed line is drawn at the level of relative
equivalence (i.e. 1/p). Figure (a) shows the first order centrality across all markers; (b)-(d) show the
results when nonsignificant markers #1-3 are iteratively nullified. Uniformity check values are also
reported: (i) the entropic difference ∆, and (ii) the corresponding empirical effective sample size (ESS)
estimates.
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(a) Scenario I (ρ = 0.5)
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(b) Scenario I (ρ = 1)
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(c) Scenario II (ρ = 0.5)
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(d) Scenario II (ρ = 1)
Figure 3. Power analysis for prioritizing genetic variants. Phenotypes are simulated with
broad-sense heritability level H2 = 0.3 with control parameter ρ = {0.5, 1} in Figures (a) and (c) and
Figures (b) and (d), respectively. Here, (1− ρ) is used to determine the proportion of signal that is
contributed by interaction effects. Compared approaches include Gaussian process regression with
RATE (blue), Bayesian variable selection with a spike and slab prior (PIPs) (pink), lasso regression
(red), the elastic net (green), and the SCANONE method (orange). Area under the curve (AUC) is
reported to facilitate comparisons. Scenario I corresponds to phenotypic outcomes being generated via
simulation model (i). Scenarios II introduces population stratification effects with simulation model (ii)
by allowing the top 5 genotype PCs to make up 30% of the phenotypic variance. Results are based on
100 replicates in each case.
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Table 1. Comparing RATE and the SCANONE mapping approach in the Arabidopsis
QTL study. Glucosinolate content traits include: allyl content, indol-3-ylmethyl (I3M),
4-methoxy-indol-3-ylmethyl (MO4I3M), 4-methylsulfinylbutyl (MSO4), 8-methylthiooctyl (MT8), and
3-hydroxypropyl (OHP3). Significant markers are determined by RATE(β˜) > 1/p and P < 9× 10−5,
respectively. The latter represents the genome-wide Bonferroni-corrected significance threshold. Values
in bold denote the best according to R2 when considering “optimal” model fit with the significant
markers. The last section describes the percent overlap between the significant markers found using the
two methods.
Phenotypic Traits
Category Method Allyl I3M MO4I3M MSO4 MT8 OHP3
# Sig. Markers
RATE 64 130 165 117 85 96
SCANONE 61 75 99 100 71 98
R2 of Sig. Model
RATE 0.686 0.472 0.570 0.544 0.610 0.569
SCANONE 0.675 0.353 0.452 0.494 0.527 0.566
% Overlap SCANONE ⊆ RATE 97% 100% 98% 100% 100% 97%
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Figure 4. Genetic map wide scan for the 4-methoxy-indol-3-ylmethyl (MO4I3M)
glucosinolate trait analyzed in Arabidopsis thaliana QTL mapping study. Compared
methods are (a) Gaussian process regression with RATE and (b) SCANONE (orange). Significant
markers are determined by RATE(β˜) > 1/p and P < 9× 10−5, respectively. The latter represents the
genome-wide Bonferroni-corrected significance threshold. To ease the comparisons, points in blue
represent genetic markers with significant distributional centrality measures. Markers labeled in color
were not found by RATE.
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(b) SCANONE
Figure 5. Genome-wide scan for high-density lipoprotein (HDL) content in the
heterogeneous stock of mice dataset. Figure (a) depicts the relative distributional centrality
measures (RATE) of quality-control-positive SNPs plotted against their genomic positions. Gaussian
process regression was used to derive these measures. Chromosomes are shown in alternating colors for
clarity, with the top five most enriched regions (according to RATE) being highlighted by the star
symbol. Figure (b) serves as a direct comparison and depicts results from a typical GWAS analysis
using SCANONE. Here, we overlay the enriched regions detected by RATE to simplify the comparison.
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